{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:44:43Z","timestamp":1790775883006,"version":"4.1.0"},"reference-count":208,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T00:00:00Z","timestamp":1691452800000},"content-version":"am","delay-in-days":341,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001819","name":"International Rett Syndrome Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-MH118351"],"award-info":[{"award-number":["R01-MH118351"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-19-1-0022"],"award-info":[{"award-number":["W81XWH-19-1-0022"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Genetics"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.tig.2022.01.007","type":"journal-article","created":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T16:11:36Z","timestamp":1646237496000},"page":"920-943","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Selective Xi reactivation and alternative methods to restore MECP2 function in Rett syndrome"],"prefix":"10.1016","volume":"38","author":[{"given":"Niklas-Benedikt","family":"Grimm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannie T.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tig.2022.01.007_bb0005","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1146\/annurev-genet-110711-155454","article-title":"Dosage compensation of the sex chromosomes","volume":"46","author":"Disteche","year":"2012","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.tig.2022.01.007_bb0010","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nrm3231","article-title":"Gracefully ageing at 50, X-chromosome inactivation becomes a paradigm for RNA and chromatin control","volume":"12","author":"Lee","year":"2011","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.tig.2022.01.007_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1242\/dev.025908","article-title":"A new model for random X chromosome inactivation","volume":"136","author":"Starmer","year":"2009","journal-title":"Development"},{"key":"10.1016\/j.tig.2022.01.007_bb0020","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/s41436-020-0779-4","article-title":"X-linked diseases: susceptible females","volume":"22","author":"Migeon","year":"2020","journal-title":"Genet. Med."},{"key":"10.1016\/j.tig.2022.01.007_bb0025","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1093\/hmg\/ddi112","article-title":"X-linked genes and mental functioning","volume":"14","author":"Skuse","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tig.2022.01.007_bb0030","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1750-1172-7-24","article-title":"Past, present and future of hemophilia: a narrative review","volume":"7","author":"Franchini","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.tig.2022.01.007_bb0035","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ajhg.2011.11.021","article-title":"Deletion of KDM6A, a histone demethylase interacting with MLL2, in three patients with Kabuki syndrome","volume":"90","author":"Lederer","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.tig.2022.01.007_bb0040","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrg3897","article-title":"Rett syndrome: a complex disorder with simple roots","volume":"16","author":"Lyst","year":"2015","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.tig.2022.01.007_bb0045","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41583-018-0006-3","article-title":"Rett syndrome: insights into genetic, molecular and circuit mechanisms","volume":"19","author":"Ip","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tig.2022.01.007_bb0050","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1086\/426462","article-title":"Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation","volume":"75","author":"Weaving","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.tig.2022.01.007_bb0055","first-page":"129","article-title":"Fragile X syndrome. Molecular and clinical insights and treatment issues","volume":"166","author":"Hagerman","year":"1997","journal-title":"West J. Med."},{"key":"10.1016\/j.tig.2022.01.007_bb0060","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41439-019-0081-7","article-title":"Novel USP9X variants in two patients with X-linked intellectual disability","volume":"6","author":"Tsurusaki","year":"2019","journal-title":"Hum. Genome Var."},{"key":"10.1016\/j.tig.2022.01.007_bb0065","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ajhg.2015.07.004","article-title":"Mutations in DDX3X are a common cause of unexplained intellectual disability with gender-specific effects on Wnt signaling","volume":"97","author":"Snijders Blok","year":"2015","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.tig.2022.01.007_bb0070","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ajhg.2015.12.015","article-title":"De novo loss-of-function mutations in USP9X cause a female-specific recognizable syndrome with developmental delay and congenital malformations","volume":"98","author":"Reijnders","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.tig.2022.01.007_bb0075","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1136\/jmedgenet-2016-103909","article-title":"De novo mutations of KIAA2022 in females cause intellectual disability and intractable epilepsy","volume":"53","author":"de Lange","year":"2016","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.tig.2022.01.007_bb0080","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neuron.2007.08.018","article-title":"MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number","volume":"56","author":"Chao","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.tig.2022.01.007_bb0085","doi-asserted-by":"crossref","first-page":"12560","DOI":"10.1073\/pnas.0506071102","article-title":"Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome","volume":"102","author":"Dani","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tig.2022.01.007_bb0090","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.npep.2004.11.001","article-title":"Central penetration and stability of N-terminal tripeptide of insulin-like growth factor-I, glycine-proline-glutamate in adult rat","volume":"39","author":"Baker","year":"2005","journal-title":"Neuropeptides"},{"key":"10.1016\/j.tig.2022.01.007_bb0095","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1126\/science.290.5495.1364","article-title":"PSD-95 involvement in maturation of excitatory synapses","volume":"290","author":"El-Husseini","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.tig.2022.01.007_bb0100","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1073\/pnas.0812394106","article-title":"Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice","volume":"106","author":"Tropea","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tig.2022.01.007_bb0105","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/nn1903","article-title":"BDNF induces transport of PSD-95 to dendrites through PI3K-AKT signaling after NMDA receptor activation","volume":"10","author":"Yoshii","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tig.2022.01.007_bb0110","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13023-020-01655-7","article-title":"Fingolimod in children with Rett syndrome: the FINGORETT study","volume":"16","author":"Naegelin","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.tig.2022.01.007_bb0115","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.tips.2016.01.003","article-title":"The Sigma-1 receptor as a pluripotent modulator in living systems","volume":"37","author":"Su","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tig.2022.01.007_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134387","article-title":"Sigma-1 receptor activation ameliorates LPS-induced NO production and ROS formation through the Nrf2\/HO-1 signaling pathway in cultured astrocytes","volume":"711","author":"Wang","year":"2019","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.tig.2022.01.007_bb0125","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.biopsych.2015.08.018","article-title":"Chronic administration of the N-methyl-D-aspartate receptor antagonist ketamine improves Rett syndrome phenotype","volume":"79","author":"Patrizi","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tig.2022.01.007_bb0130","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1006\/exnr.1999.7030","article-title":"Altered development of glutamate and GABA receptors in the basal ganglia of girls with Rett syndrome","volume":"156","author":"Blue","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.tig.2022.01.007_bb0135","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1212\/WNL.0000000000004515","article-title":"Randomized open-label trial of dextromethorphan in Rett syndrome","volume":"89","author":"Smith-Hicks","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.tig.2022.01.007_bb0140","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau0164","article-title":"Pharmacological enhancement of KCC2 gene expression exerts therapeutic effects on human Rett syndrome neurons and Mecp2 mutant mice","volume":"11","author":"Tang","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tig.2022.01.007_bb0145","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s40478-019-0852-x","article-title":"KCC2 expression levels are reduced in post mortem brain tissue of Rett syndrome patients","volume":"7","author":"Hinz","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.tig.2022.01.007_bb0150","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/85906","article-title":"Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice","volume":"27","author":"Chen","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tig.2022.01.007_bb0155","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/85899","article-title":"A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome","volume":"27","author":"Guy","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tig.2022.01.007_bb0160","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1126\/science.1206593","article-title":"Adult neural function requires MeCP2","volume":"333","author":"McGraw","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.tig.2022.01.007_bb0165","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00005072-199503000-00006","article-title":"Selective dendritic alterations in the cortex of Rett syndrome","volume":"54","author":"Armstrong","year":"1995","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.tig.2022.01.007_bb0170","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1126\/science.1138389","article-title":"Reversal of neurological defects in a mouse model of Rett syndrome","volume":"315","author":"Guy","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.tig.2022.01.007_bb0175","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.14198","article-title":"Restoration of Mecp2 expression in GABAergic neurons is sufficient to rescue multiple disease features in a mouse model of Rett syndrome","volume":"5","author":"Ure","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.tig.2022.01.007_bb0180","doi-asserted-by":"crossref","first-page":"13612","DOI":"10.1523\/JNEUROSCI.1854-13.2013","article-title":"Systemic delivery of MeCP2 rescues behavioral and cellular deficits in female mouse models of Rett syndrome","volume":"33","author":"Garg","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tig.2022.01.007_bb0185","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tig.2022.01.007_bb0190","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.92.15_supplement.S51.002","article-title":"Rett syndrome gene therapy improves survival and ameliorates behavioral phenotypes in MeCP2 null (S51.002)","volume":"92","author":"Powers","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.tig.2022.01.007_bb0195","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1093\/hmg\/ddh282","article-title":"Mild overexpression of MeCP2 causes a progressive neurological disorder in mice","volume":"13","author":"Collins","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tig.2022.01.007_bb0200","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1523\/JNEUROSCI.6000-11.2012","article-title":"A mouse model for MeCP2 duplication syndrome: MeCP2 overexpression impairs learning and memory and synaptic transmission","volume":"32","author":"Na","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tig.2022.01.007_bb0205","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nature16159","article-title":"Reversal of phenotypes in MECP2 duplication mice using genetic rescue or antisense oligonucleotides","volume":"528","author":"Sztainberg","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.tig.2022.01.007_bb0210","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1093\/brain\/awab182","article-title":"Engineered microRNA-based regulatory element permits safe high-dose miniMECP2 gene therapy in Rett mice","volume":"144","author":"Sinnett","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.tig.2022.01.007_bb0215","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/mt.2012.200","article-title":"Improved survival and reduced phenotypic severity following AAV9\/MECP2 gene transfer to neonatal and juvenile male Mecp2 knockout mice","volume":"21","author":"Gadalla","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tig.2022.01.007_bb0220","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ymthe.2020.01.001","article-title":"Immune responses to viral gene therapy vectors","volume":"28","author":"Shirley","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tig.2022.01.007_bb0225","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41587-020-0741-7","article-title":"A long-term study of AAV gene therapy in dogs with hemophilia A identifies clonal expansions of transduced liver cells","volume":"39","author":"Nguyen","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tig.2022.01.007_bb0230","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.trsl.2015.09.008","article-title":"Advances in therapeutic CRISPR\/Cas9 genome editing","volume":"168","author":"Savi\u0107","year":"2016","journal-title":"Transl. Res."},{"key":"10.1016\/j.tig.2022.01.007_bb0235","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.tig.2022.01.007_bb0240","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/s41431-020-0624-x","article-title":"High rate of HDR in gene editing of p.(Thr158Met) MECP2 mutational hotspot","volume":"28","author":"Croci","year":"2020","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.tig.2022.01.007_bb0245","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00018-009-8740-3","article-title":"DNA repair in mammalian cells: DNA double-strand break repair: how to fix a broken relationship","volume":"66","author":"Pardo","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.tig.2022.01.007_bb0250","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nm.3793","article-title":"Therapeutic genome editing: prospects and challenges","volume":"21","author":"Cox","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.tig.2022.01.007_bb0255","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.molcel.2012.07.029","article-title":"Playing the end game: DNA double-strand break repair pathway choice","volume":"47","author":"Chapman","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tig.2022.01.007_bb0260","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nrn.2015.2","article-title":"Applications of CRISPR-Cas systems in neuroscience","volume":"17","author":"Heidenreich","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tig.2022.01.007_bb0265","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.celrep.2017.07.004","article-title":"The lifespan and turnover of microglia in the human brain","volume":"20","author":"R\u00e9u","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.tig.2022.01.007_bb0270","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/jnen\/64.2.163","article-title":"Proliferative potential of human astrocytes","volume":"64","author":"Colodner","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.tig.2022.01.007_bb0275","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/s41573-020-0084-6","article-title":"Base editing: advances and therapeutic opportunities","volume":"19","author":"Porto","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tig.2022.01.007_bb0280","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.tig.2022.01.007_bb0285","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature24644","article-title":"Programmable base editing of A\u2022T to G\u2022C in genomic DNA without DNA cleavage","volume":"551","author":"Gaudelli","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.tig.2022.01.007_bb0290","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/s41587-020-0453-z","article-title":"Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity","volume":"38","author":"Richter","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tig.2022.01.007_bb0295","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/s41587-020-0491-6","article-title":"Directed evolution of adenine base editors with increased activity and therapeutic application","volume":"38","author":"Gaudelli","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tig.2022.01.007_bb0300","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3389\/fnins.2017.00503","article-title":"Evaluating efficiencies of dual AAV approaches for retinal targeting","volume":"11","author":"Carvalho","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.tig.2022.01.007_bb0305","doi-asserted-by":"crossref","first-page":"6450","DOI":"10.1093\/nar\/gkv601","article-title":"Development of an intein-mediated split-Cas9 system for gene therapy","volume":"43","author":"Truong","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tig.2022.01.007_bb0310","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41551-019-0501-5","article-title":"Cytosine and adenine base editing of the brain, liver, retina, heart and skeletal muscle of mice via adeno-associated viruses","volume":"4","author":"Levy","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.tig.2022.01.007_bb0315","doi-asserted-by":"crossref","first-page":"18285","DOI":"10.1073\/pnas.1306243110","article-title":"Correction of mutations within the cystic fibrosis transmembrane conductance regulator by site-directed RNA editing","volume":"110","author":"Montiel-Gonzalez","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.tig.2022.01.007_bb0320","doi-asserted-by":"crossref","first-page":"41478","DOI":"10.1038\/srep41478","article-title":"Construction of a guide-RNA for site-directed RNA mutagenesis utilising intracellular A-to-I RNA editing","volume":"7","author":"Fukuda","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tig.2022.01.007_bb0325","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nsmb.3203","article-title":"Structures of human ADAR2 bound to dsRNA reveal base-flipping mechanism and basis for site selectivity","volume":"23","author":"Matthews","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.tig.2022.01.007_bb0330","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1017\/S135583820101007X","article-title":"Substrate recognition by ADAR1 and ADAR2","volume":"7","author":"Wong","year":"2001","journal-title":"RNA"},{"key":"10.1016\/j.tig.2022.01.007_bb0335","doi-asserted-by":"crossref","first-page":"E9395","DOI":"10.1073\/pnas.1715320114","article-title":"Site-directed RNA repair of endogenous Mecp2 RNA in neurons","volume":"114","author":"Sinnamon","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tig.2022.01.007_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107878","article-title":"In vivo repair of a protein underlying a neurological disorder by programmable RNA editing","volume":"32","author":"Sinnamon","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.tig.2022.01.007_bb0345","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41592-019-0323-0","article-title":"In vivo RNA editing of point mutations via RNA-guided adenosine deaminases","volume":"16","author":"Katrekar","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.tig.2022.01.007_bb0350","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41597-020-00794-7","article-title":"A catalogue of 863 Rett-syndrome-causing MECP2 mutations and lessons learned from data integration","volume":"8","author":"Ehrhart","year":"2021","journal-title":"Sci. Data"},{"key":"10.1016\/j.tig.2022.01.007_bb0355","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1126\/science.aax7063","article-title":"A cytosine deaminase for programmable single-base RNA editing","volume":"365","author":"Abudayyeh","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.tig.2022.01.007_bb0360","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1126\/science.aaq0180","article-title":"RNA editing with CRISPR-Cas13","volume":"358","author":"Cox","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.tig.2022.01.007_bb0365","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41592-018-0017-z","article-title":"Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs","volume":"15","author":"Vogel","year":"2018","journal-title":"Nat. Methods"},{"key":"10.1016\/j.tig.2022.01.007_bb0370","series-title":"RNA Editing: Methods and Protocols","first-page":"331","article-title":"New frontiers for site-directed RNA editing: harnessing endogenous ADARs","author":"Merkle","year":"2021"},{"key":"10.1016\/j.tig.2022.01.007_bb0375","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41592-019-0380-4","article-title":"RNA editing with endogenous ADARs","volume":"16","author":"Rusk","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.tig.2022.01.007_bb0380","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41587-019-0013-6","article-title":"Precise RNA editing by recruiting endogenous ADARs with antisense oligonucleotides","volume":"37","author":"Merkle","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tig.2022.01.007_bb0385","first-page":"2797","article-title":"Harnessing human ADAR2 for RNA repair - recoding a PINK1 mutation rescues mitophagy","volume":"45","author":"Wettengel","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tig.2022.01.007_bb0390","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1126\/science.1122984","article-title":"Transient homologous chromosome pairing marks the onset of X inactivation","volume":"311","author":"Xu","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.tig.2022.01.007_bb0395","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/ncb1365","article-title":"Transient colocalization of X-inactivation centres accompanies the initiation of X inactivation","volume":"8","author":"Bacher","year":"2006","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.tig.2022.01.007_bb0400","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/nsmb.3432","article-title":"PAR-TERRA directs homologous sex chromosome pairing","volume":"24","author":"Chu","year":"2017","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.tig.2022.01.007_bb0405","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/7734","article-title":"Tsix, a gene antisense to Xist at the X-inactivation centre","volume":"21","author":"Lee","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tig.2022.01.007_bb0410","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cell.2011.06.026","article-title":"YY1 tethers Xist RNA to the inactive X nucleation center","volume":"146","author":"Jeon","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.tig.2022.01.007_bb0415","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nature12719","article-title":"High-resolution Xist binding maps reveal two-step spreading during X-chromosome inactivation","volume":"504","author":"Simon","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.tig.2022.01.007_bb0420","doi-asserted-by":"crossref","DOI":"10.1126\/science.1237973","article-title":"The Xist lncRNA exploits three-dimensional genome architecture to spread across the X chromosome","volume":"341","author":"Engreitz","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.tig.2022.01.007_bb0425","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.cell.2018.05.007","article-title":"SMCHD1 merges chromosome compartments and assists formation of super-structures on the inactive X","volume":"174","author":"Wang","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.tig.2022.01.007_bb0430","doi-asserted-by":"crossref","DOI":"10.1126\/science.aab2276","article-title":"Chromosomes. A comprehensive Xist interactome reveals cohesin repulsion and an RNA-directed chromosome conformation","volume":"349","author":"Minajigi","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.tig.2022.01.007_bb0435","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1126\/science.1163045","article-title":"Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome","volume":"322","author":"Zhao","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.tig.2022.01.007_bb0440","doi-asserted-by":"crossref","first-page":"E4216","DOI":"10.1073\/pnas.1503690112","article-title":"The Xist RNA-PRC2 complex at 20-nm resolution reveals a low Xist stoichiometry and suggests a hit-and-run mechanism in mouse cells","volume":"112","author":"Sunwoo","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tig.2022.01.007_bb0445","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1126\/science.1084274","article-title":"Role of histone H3 lysine 27 methylation in X inactivation","volume":"300","author":"Plath","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.tig.2022.01.007_bb0450","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1101\/gr.133751.111","article-title":"Spreading of X chromosome inactivation via a hierarchy of defined Polycomb stations","volume":"22","author":"Pinter","year":"2012","journal-title":"Genome Res."},{"key":"10.1016\/j.tig.2022.01.007_bb0455","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1083\/jcb.153.4.773","article-title":"Synergism of Xist RNA, DNA methylation, and histone hypoacetylation in maintaining X chromosome inactivation","volume":"153","author":"Csankovszki","year":"2001","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.tig.2022.01.007_bb0460","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0092-8674(93)90419-Q","article-title":"The inactive X chromosome in female mammals is distinguished by a lack of histone H4 acetylation, a cytogenetic marker for gene expression","volume":"74","author":"Jeppesen","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.tig.2022.01.007_bb0465","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1242\/dev.00995","article-title":"De novo DNA methylation is dispensable for the initiation and propagation of X chromosome inactivation","volume":"131","author":"Sado","year":"2004","journal-title":"Development"},{"key":"10.1016\/j.tig.2022.01.007_bb0470","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41586-020-1974-9","article-title":"SPEN integrates transcriptional and epigenetic control of X-inactivation","volume":"578","author":"Dossin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.tig.2022.01.007_bb0475","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nature14443","article-title":"The Xist lncRNA interacts directly with SHARP to silence transcription through HDAC3","volume":"521","author":"McHugh","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.tig.2022.01.007_bb0480","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nsmb.2476","article-title":"Nuclear receptor co-repressors are required for the histone-deacetylase activity of HDAC3 in vivo","volume":"20","author":"You","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.tig.2022.01.007_bb0485","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.cell.2018.11.041","article-title":"The implication of early chromatin changes in X chromosome inactivation","volume":"176","author":"\u017bylicz","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.tig.2022.01.007_bb0490","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nature19342","article-title":"m(6)A RNA methylation promotes XIST-mediated transcriptional repression","volume":"537","author":"Patil","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.tig.2022.01.007_bb0495","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41594-018-0176-8","article-title":"Xist RNA antagonizes the SWI\/SNF chromatin remodeler BRG1 on the inactive X chromosome","volume":"26","author":"J\u00e9gu","year":"2019","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.tig.2022.01.007_bb0500","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41576-019-0128-0","article-title":"Long-range enhancer-promoter contacts in gene expression control","volume":"20","author":"Schoenfelder","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.tig.2022.01.007_bb0505","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41580-019-0132-4","article-title":"The role of 3D genome organization in development and cell differentiation","volume":"20","author":"Zheng","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.tig.2022.01.007_bb0510","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1126\/science.1181369","article-title":"Comprehensive mapping of long-range interactions reveals folding principles of the human genome","volume":"326","author":"Lieberman-Aiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.tig.2022.01.007_bb0515","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature11082","article-title":"Topological domains in mammalian genomes identified by analysis of chromatin interactions","volume":"485","author":"Dixon","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.tig.2022.01.007_bb0520","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.cell.2014.11.021","article-title":"A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping","volume":"159","author":"Rao","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.tig.2022.01.007_bb0525","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41588-019-0561-1","article-title":"On the existence and functionality of topologically associating domains","volume":"52","author":"Beagan","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tig.2022.01.007_bb0530","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nature18589","article-title":"Structural organization of the inactive X chromosome in the mouse","volume":"535","author":"Giorgetti","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.tig.2022.01.007_bb0535","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nrg.2017.17","article-title":"The X chromosome in space","volume":"18","author":"J\u00e9gu","year":"2017","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.tig.2022.01.007_bb0540","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1609643113","article-title":"Deletion of DXZ4 on the human inactive X chromosome alters higher-order genome architecture","volume":"113","author":"Darrow","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tig.2022.01.007_bb0545","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/s41467-018-03694-y","article-title":"Orientation-dependent Dxz4 contacts shape the 3D structure of the inactive X chromosome","volume":"9","author":"Bonora","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tig.2022.01.007_bb0550","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41467-018-07907-2","article-title":"The non-canonical SMC protein SmcHD1 antagonises TAD formation and compartmentalisation on the inactive X chromosome","volume":"10","author":"Gdula","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tig.2022.01.007_bb0555","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1038\/s41467-019-10755-3","article-title":"PRC1 collaborates with SMCHD1 to fold the X-chromosome and spread Xist RNA between chromosome compartments","volume":"10","author":"Wang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tig.2022.01.007_bb0560","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.molcel.2017.11.013","article-title":"hnRNPK recruits PCGF3\/5-PRC1 to the Xist RNA B-repeat to establish polycomb-mediated chromosomal silencing","volume":"68","author":"Pintacuda","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tig.2022.01.007_bb0565","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/s41594-018-0111-z","article-title":"Smchd1 regulates long-range chromatin interactions on the inactive X chromosome and at Hox clusters","volume":"25","author":"Jansz","year":"2018","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.tig.2022.01.007_bb0570","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.celrep.2018.10.044","article-title":"Smchd1 targeting to the inactive X is dependent on the Xist-HnrnpK-PRC1 pathway","volume":"25","author":"Jansz","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.tig.2022.01.007_bb0575","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.cell.2013.01.034","article-title":"Xist RNA is a potent suppressor of hematologic cancer in mice","volume":"152","author":"Yildirim","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.tig.2022.01.007_bb0580","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/368154a0","article-title":"The human X-inactivation centre is not required for maintenance of X-chromosome inactivation","volume":"368","author":"Brown","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.tig.2022.01.007_bb0585","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S1097-2765(00)80248-8","article-title":"A shift from reversible to irreversible X inactivation is triggered during ES cell differentiation","volume":"5","author":"Wutz","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tig.2022.01.007_bb0590","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/11887","article-title":"Conditional deletion of Xist disrupts histone macroH2A localization but not maintenance of X inactivation","volume":"22","author":"Csankovszki","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tig.2022.01.007_bb0595","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2007.03.036","article-title":"Perinucleolar targeting of the inactive X during S phase: evidence for a role in the maintenance of silencing","volume":"129","author":"Zhang","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.tig.2022.01.007_bb0600","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1101\/gad.11.2.156","article-title":"Xist-deficient mice are defective in dosage compensation but not spermatogenesis","volume":"11","author":"Marahrens","year":"1997","journal-title":"Genes Dev."},{"key":"10.1016\/j.tig.2022.01.007_bb0605","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1101\/gad.281162.116","article-title":"Female mice lacking Xist RNA show partial dosage compensation and survive to term","volume":"30","author":"Yang","year":"2016","journal-title":"Genes Dev."},{"key":"10.1016\/j.tig.2022.01.007_bb0610","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1073\/pnas.1917203117","article-title":"Widespread organ tolerance to Xist loss and X reactivation except under chronic stress in the gut","volume":"117","author":"Yang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tig.2022.01.007_bb0615","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13072-018-0219-8","article-title":"Perturbed maintenance of transcriptional repression on the inactive X-chromosome in the mouse brain after Xist deletion","volume":"11","author":"Adrianse","year":"2018","journal-title":"Epigenetics Chromatin"},{"key":"10.1016\/j.tig.2022.01.007_bb0620","doi-asserted-by":"crossref","first-page":"E668","DOI":"10.1073\/pnas.1715124115","article-title":"A mixed modality approach towards Xi reactivation for Rett syndrome and other X-linked disorders","volume":"115","author":"Carrette","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tig.2022.01.007_bb0625","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nature09582","article-title":"Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes","volume":"468","author":"Chao","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.tig.2022.01.007_bb0630","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1523\/JNEUROSCI.4900-12.2014","article-title":"Loss of MeCP2 from forebrain excitatory neurons leads to cortical hyperexcitation and seizures","volume":"34","author":"Zhang","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tig.2022.01.007_bb0635","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1038\/nature14444","article-title":"Wild-type microglia do not reverse pathology in mouse models of Rett syndrome","volume":"521","author":"Wang","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.tig.2022.01.007_bb0640","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature10907","article-title":"Wild-type microglia arrest pathology in a mouse model of Rett syndrome","volume":"484","author":"Derecki","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.tig.2022.01.007_bb0645","doi-asserted-by":"crossref","first-page":"8185","DOI":"10.1073\/pnas.1800931115","article-title":"Tsix-Mecp2 female mouse model for Rett syndrome reveals that low-level MECP2 expression extends life and improves neuromotor function","volume":"115","author":"Carrette","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tig.2022.01.007_bb0650","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.expneurol.2009.12.007","article-title":"MeCP2 functions largely cell-autonomously, but also non-cell-autonomously, in neuronal maturation and dendritic arborization of cortical pyramidal neurons","volume":"222","author":"Kishi","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.tig.2022.01.007_bb0655","doi-asserted-by":"crossref","first-page":"16699","DOI":"10.1073\/pnas.1107616108","article-title":"Diverse factors are involved in maintaining X chromosome inactivation","volume":"108","author":"Chan","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tig.2022.01.007_bb0660","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.tibs.2015.12.003","article-title":"Fitting the puzzle pieces: the bigger picture of XCI","volume":"41","author":"Maduro","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.tig.2022.01.007_bb0665","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1073\/pnas.1621356114","article-title":"Screen for reactivation of MeCP2 on the inactive X chromosome identifies the BMP\/TGF-\u03b2 superfamily as a regulator of XIST expression","volume":"114","author":"Sripathy","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tig.2022.01.007_bb0670","doi-asserted-by":"crossref","first-page":"14366","DOI":"10.1073\/pnas.1617597113","article-title":"A high-throughput small molecule screen identifies synergism between DNA methylation and Aurora kinase pathways for X reactivation","volume":"113","author":"Lessing","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tig.2022.01.007_bb0675","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1756-8935-7-12","article-title":"The Mbd1-Atf7ip-Setdb1 pathway contributes to the maintenance of X chromosome inactivation","volume":"7","author":"Minkovsky","year":"2014","journal-title":"Epigenetics Chromatin"},{"key":"10.1016\/j.tig.2022.01.007_bb0680","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13072-015-0034-4","article-title":"A high-throughput screen of inactive X chromosome reactivation identifies the enhancement of DNA demethylation by 5-aza-2'-dC upon inhibition of ribonucleotide reductase","volume":"8","author":"Minkovsky","year":"2015","journal-title":"Epigenetics Chromatin"},{"key":"10.1016\/j.tig.2022.01.007_bb0685","doi-asserted-by":"crossref","first-page":"12591","DOI":"10.1073\/pnas.1413620111","article-title":"Genetic and pharmacological reactivation of the mammalian inactive X chromosome","volume":"111","author":"Bhatnagar","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tig.2022.01.007_bb0690","doi-asserted-by":"crossref","first-page":"12893","DOI":"10.18632\/oncotarget.7335","article-title":"MLN-8237: a dual inhibitor of aurora A and B in soft tissue sarcomas","volume":"7","author":"Nair","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.tig.2022.01.007_bb0695","article-title":"Genetic and epigenetic determinants of reactivation of Mecp2 and the inactive X chromosome in neural stem cells","author":"Mira-Bontenbal","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.tig.2022.01.007_bb0700","doi-asserted-by":"crossref","first-page":"7991","DOI":"10.1073\/pnas.1803792115","article-title":"Pharmacological reactivation of inactive X-linked Mecp2 in cerebral cortical neurons of living mice","volume":"115","author":"Przanowski","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tig.2022.01.007_bb0705","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s11689-020-09332-3","article-title":"A small-molecule screen reveals novel modulators of MeCP2 and X-chromosome inactivation maintenance","volume":"12","author":"Lee","year":"2020","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.tig.2022.01.007_bb0710","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrneurol.2017.148","article-title":"Antisense oligonucleotides: the next frontier for treatment of neurological disorders","volume":"14","author":"Rinaldi","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.tig.2022.01.007_bb0715","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","article-title":"Advances in oligonucleotide drug delivery","volume":"19","author":"Roberts","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tig.2022.01.007_bb0720","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0014-5793(95)00517-D","article-title":"Phosphorothioate oligonucleotides bind in a non sequence-specific manner to the nucleolar protein C23\/nucleolin","volume":"366","author":"Weidner","year":"1995","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tig.2022.01.007_bb0725","doi-asserted-by":"crossref","first-page":"321","DOI":"10.4161\/rna.6.3.8807","article-title":"Locked nucleic acid as a novel class of therapeutic agents","volume":"6","author":"Veedu","year":"2009","journal-title":"RNA Biol."},{"key":"10.1016\/j.tig.2022.01.007_bb0730","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/nar\/gkl1071","article-title":"Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals","volume":"35","author":"Swayze","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tig.2022.01.007_bb0735","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1093\/nar\/gkaa126","article-title":"Comparison of the efficacy of MOE and PMO modifications of systemic antisense oligonucleotides in a severe SMA mouse model","volume":"48","author":"Sheng","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tig.2022.01.007_bb0740","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1056\/NEJMoa1605949","article-title":"TP53 and decitabine in acute myeloid leukemia and myelodysplastic syndromes","volume":"375","author":"Welch","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tig.2022.01.007_bb0745","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/00001813-199704000-00008","article-title":"Pilot phase I-II study on 5-aza-2'-deoxycytidine (Decitabine) in patients with metastatic lung cancer","volume":"8","author":"Momparler","year":"1997","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.tig.2022.01.007_bb0750","article-title":"Plasma and cerebrospinal fluid pharmacokinetics of the DNA methyltransferase inhibitor, 5-azacytidine, alone and with inulin, in nonhuman primate models","volume":"2","author":"McCully","year":"2020","journal-title":"Neuro Oncol. Adv."},{"key":"10.1016\/j.tig.2022.01.007_bb0755","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.tins.2019.10.003","article-title":"Editing the epigenome to tackle brain disorders","volume":"42","author":"Liu","year":"2019","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.tig.2022.01.007_bb0760","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cell.2016.08.056","article-title":"Editing DNA methylation in the mammalian genome","volume":"167","author":"Liu","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.tig.2022.01.007_bb0765","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41583-020-0334-y","article-title":"In vivo locus-specific editing of the neuroepigenome","volume":"21","author":"Yim","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tig.2022.01.007_bb0770","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1093\/nar\/gkz1214","article-title":"Artificial escape from XCI by DNA methylation editing of the CDKL5 gene","volume":"48","author":"Halmai","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tig.2022.01.007_bb0775","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/cge.13674","article-title":"Chromatinopathies: a focus on Cornelia de Lange syndrome","volume":"97","author":"Avagliano","year":"2020","journal-title":"Clin. Genet."},{"key":"10.1016\/j.tig.2022.01.007_bb0780","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.molcel.2010.01.030","article-title":"Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state","volume":"37","author":"Skene","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tig.2022.01.007_bb0785","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nature10214","article-title":"A role for glia in the progression of Rett's syndrome","volume":"475","author":"Lioy","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.tig.2022.01.007_bb0790","doi-asserted-by":"crossref","first-page":"30101","DOI":"10.1074\/jbc.M804613200","article-title":"CDKL5 expression is modulated during neuronal development and its subcellular distribution is tightly regulated by the C-terminal tail","volume":"283","author":"Rusconi","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tig.2022.01.007_bb0795","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2","volume":"23","author":"Amir","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tig.2022.01.007_bb0800","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1086\/302690","article-title":"Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots","volume":"65","author":"Wan","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.tig.2022.01.007_bb0805","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/ana.22124","article-title":"Rett syndrome: revised diagnostic criteria and nomenclature","volume":"68","author":"Neul","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tig.2022.01.007_bb0810","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrneurol.2016.186","article-title":"Clinical and biological progress over 50 years in Rett syndrome","volume":"13","author":"Leonard","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.tig.2022.01.007_bb0815","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.pediatrneurol.2012.11.001","article-title":"Rett syndrome and epilepsy: an update for child neurologists","volume":"48","author":"Dolce","year":"2013","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.tig.2022.01.007_bb0820","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2013.65","article-title":"Lipid nanoparticle delivery of siRNA to silence neuronal gene expression in the brain","volume":"2","author":"Rungta","year":"2013","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.tig.2022.01.007_bb0825","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines \u2014 a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tig.2022.01.007_bb0830","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/vaccines9010065","article-title":"Nanomaterial delivery systems for mRNA vaccines","volume":"9","author":"Buschmann","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.tig.2022.01.007_bb0835","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nmat3765","article-title":"Delivery materials for siRNA therapeutics","volume":"12","author":"Kanasty","year":"2013","journal-title":"Nat. Mater."},{"key":"10.1016\/j.tig.2022.01.007_bb0840","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ymthe.2018.12.011","article-title":"Improving mRNA-based therapeutic gene delivery by expression-augmenting 3' UTRs identified by cellular library screening","volume":"27","author":"von Niessen","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tig.2022.01.007_bb0845","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1261\/rna.069286.118","article-title":"Segmented poly(A) tails significantly reduce recombination of plasmid DNA without affecting mRNA translation efficiency or half-life","volume":"25","author":"Trepotec","year":"2019","journal-title":"RNA"},{"key":"10.1016\/j.tig.2022.01.007_bb0850","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd4278","article-title":"mRNA-based therapeutics \u2014 developing a new class of drugs","volume":"13","author":"Sahin","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tig.2022.01.007_bb0855","article-title":"Cap 1 messenger RNA synthesis with co-transcriptional CleanCap\u00ae analog by in vitro transcription","volume":"1","author":"Henderson","year":"2021","journal-title":"Curr. Protoc."},{"key":"10.1016\/j.tig.2022.01.007_bb0860","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1038\/s41467-021-24436-7","article-title":"High-throughput 5\u2032 UTR engineering for enhanced protein production in non-viral gene therapies","volume":"12","author":"Cao","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tig.2022.01.007_bb0865","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkr695","article-title":"Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA","volume":"39","author":"Karik\u00f3","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tig.2022.01.007_bb0870","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.cell.2014.08.028","article-title":"Transcriptome-wide mapping reveals widespread dynamic-regulated pseudouridylation of ncRNA and mRNA","volume":"159","author":"Schwartz","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.tig.2022.01.007_bb0875","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA","volume":"23","author":"Karik\u00f3","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.tig.2022.01.007_bb0880","doi-asserted-by":"crossref","first-page":"5884","DOI":"10.1093\/nar\/gkq347","article-title":"Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation","volume":"38","author":"Anderson","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tig.2022.01.007_bb0885","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.1093\/nar\/gkx135","article-title":"N1-methyl-pseudouridine in mRNA enhances translation through eIF2\u03b1-dependent and independent mechanisms by increasing ribosome density","volume":"45","author":"Svitkin","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tig.2022.01.007_bb0890","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jddst.2015.07.007","article-title":"The \u2018fate\u2019 of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood\u2013brain barrier crossing and trafficking into the central nervous system","volume":"32","author":"Tosi","year":"2016","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.tig.2022.01.007_bb0895","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1146\/annurev-genom-091212-153527","article-title":"Therapeutics based on stop codon readthrough","volume":"15","author":"Keeling","year":"2014","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.tig.2022.01.007_bb0900","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00109-010-0704-4","article-title":"Readthrough of nonsense mutations in Rett syndrome: evaluation of novel aminoglycosides and generation of a new mouse model","volume":"89","author":"Brendel","year":"2011","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.tig.2022.01.007_bb0905","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020733","article-title":"Ex vivo treatment with a novel synthetic aminoglycoside NB54 in primary fibroblasts from Rett syndrome patients suppresses MECP2 nonsense mutations","volume":"6","author":"Vecsler","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tig.2022.01.007_bb0910","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1093\/hmg\/ddv030","article-title":"Rett syndrome like phenotypes in the R255X Mecp2 mutant mouse are rescued by MECP2 transgene","volume":"24","author":"Pitcher","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tig.2022.01.007_bb0915","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1021\/bi00600a001","article-title":"Aminoglycoside antibiotics and eukaryotic protein synthesis: structure-function relationships in the stimulation of misreading with a wheat embryo system","volume":"17","author":"Wilhelm","year":"1978","journal-title":"Biochemistry"},{"key":"10.1016\/j.tig.2022.01.007_bb0920","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/277148a0","article-title":"Phenotypic suppression of nonsense mutants in yeast by aminoglycoside antibiotics","volume":"277","author":"Palmer","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.tig.2022.01.007_bb0925","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1128\/CMR.00007-10","article-title":"Penetration of drugs through the blood-cerebrospinal fluid\/blood-brain barrier for treatment of central nervous system infections","volume":"23","author":"Nau","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.tig.2022.01.007_bb0930","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-61779-921-1_1","article-title":"Therapeutic proteins","volume":"899","author":"Dimitrov","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.tig.2022.01.007_bb0935","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ymgme.2019.11.007","article-title":"Intrathecal enzyme replacement for cognitive decline in mucopolysaccharidosis type I, a randomized, open-label, controlled pilot study","volume":"129","author":"Chen","year":"2020","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.tig.2022.01.007_bb0940","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13023-018-0849-8","article-title":"Neurocognitive and somatic stabilization in pediatric patients with severe Mucopolysaccharidosis Type I after 52 weeks of intravenous brain-penetrating insulin receptor antibody-iduronidase fusion protein (valanafusp alpha): an open label phase 1-2 trial","volume":"13","author":"Giugliani","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.tig.2022.01.007_bb0945","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3389\/fnagi.2019.00373","article-title":"Blood-brain barrier and delivery of protein and gene therapeutics to brain","volume":"11","author":"Pardridge","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.tig.2022.01.007_bb0950","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3389\/fncel.2014.00236","article-title":"MeCP2 post-translational modifications: a mechanism to control its involvement in synaptic plasticity and homeostasis?","volume":"8","author":"Bellini","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.tig.2022.01.007_bb0955","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/163676a0","article-title":"A morphological distinction between neurones of the male and female, and the behaviour of the nucleolar satellite during accelerated nucleoprotein synthesis","volume":"163","author":"Barr","year":"1949","journal-title":"Nature"},{"key":"10.1016\/j.tig.2022.01.007_bb0960","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0014-4827(59)90031-X","article-title":"Formation of the sex chromatin by a single X-chromosome in liver cells of Rattus norvegicus","volume":"18","author":"Ohno","year":"1959","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.tig.2022.01.007_bb0965","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/190372a0","article-title":"Gene action in the X-chromosome of the mouse (Mus musculus L.)","volume":"190","author":"Lyon","year":"1961","journal-title":"Nature"},{"key":"10.1016\/j.tig.2022.01.007_bb0970","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/newbio232229a0","article-title":"Possible mechanisms of X chromosome inactivation","volume":"232","author":"Lyon","year":"1971","journal-title":"Nat. New Biol."},{"key":"10.1016\/j.tig.2022.01.007_bb0975","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1469-185X.1972.tb00969.x","article-title":"X-chromosome inactivation and developmental patterns in mammals","volume":"47","author":"Lyon","year":"1972","journal-title":"Biol. Rev."},{"key":"10.1016\/j.tig.2022.01.007_bb0980","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/349082a0","article-title":"Localization of the X inactivation centre on the human X chromosome in Xq13","volume":"349","author":"Brown","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.tig.2022.01.007_bb0985","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0092-8674(00)80079-3","article-title":"A 450 kb transgene displays properties of the mammalian X-inactivation center","volume":"86","author":"Lee","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.tig.2022.01.007_bb0990","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/349038a0","article-title":"A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome","volume":"349","author":"Brown","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.tig.2022.01.007_bb0995","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/379131a0","article-title":"Requirement for Xist in X chromosome inactivation","volume":"379","author":"Penny","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.tig.2022.01.007_bb1000","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nature24265","article-title":"Landscape of X chromosome inactivation across human tissues","volume":"550","author":"Tukiainen","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.tig.2022.01.007_bb1005","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature03479","article-title":"X-inactivation profile reveals extensive variability in X-linked gene expression in females","volume":"434","author":"Carrel","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.tig.2022.01.007_bb1010","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1016\/S0140-6736(16)31408-8","article-title":"Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study","volume":"388","author":"Finkel","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.tig.2022.01.007_bb1015","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105218","article-title":"Exosome-mediated delivery of antisense oligonucleotides targeting \u03b1-synuclein ameliorates the pathology in a mouse model of Parkinson's disease","volume":"148","author":"Yang","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tig.2022.01.007_bb1020","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1807","article-title":"Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes","volume":"29","author":"Alvarez-Erviti","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tig.2022.01.007_bb1025","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41580-020-0251-y","article-title":"RNA delivery by extracellular vesicles in mammalian cells and its applications","volume":"21","author":"O\u2019Brien","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.tig.2022.01.007_bb2005","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1002\/jnr.22409","article-title":"Aminoglycoside-mediated partial suppression of MECP2 nonsense mutations responsible for Rett syndrome in vitro","volume":"88","author":"Popescu","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.tig.2022.01.007_bb2010","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.cell.2021.12.021","article-title":"Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins","volume":"185","author":"Banskota","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.tig.2022.01.007_bb2015","doi-asserted-by":"crossref","DOI":"10.1038\/s41587-021-01171-4","article-title":"Efficient in vitro and in vivo RNA editing via recruitment of endogenous ADARs using circular guide RNAs","author":"Katrekar","year":"2022","journal-title":"Nat. Biotechnol."}],"container-title":["Trends in Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168952522000075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168952522000075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:14:16Z","timestamp":1759191256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168952522000075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":208,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0168952522000075"],"URL":"https:\/\/doi.org\/10.1016\/j.tig.2022.01.007","relation":{},"ISSN":["0168-9525"],"issn-type":[{"value":"0168-9525","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective Xi reactivation and alternative methods to restore MECP2 function in Rett syndrome","name":"articletitle","label":"Article Title"},{"value":"Trends in Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tig.2022.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}